Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Air Liquide Advanced Business S.A. and its wholly owned subsidiary FordonsGas Sverige AB
Mandate

Vinge advises Air Liquide Advanced Business S.A. and its wholly owned subsidiary FordonsGas Sverige AB

March 02, 2016

Vinge advises Air Liquide Advanced Business S.A. and its wholly owned subsidiary FordonsGas Sverige AB in connection with the acquistion of Lidköping Biogas AB. Lidköping Biogas produces liquid biogas for inter alia trucks and has an annual capacity of 60 GWh.

FordonsGas operates and builds gas tank stations in Sweden, and currenly operates more than 40 gas tank stations, predominantly in the western part of Sweden. Through the acquisition of Lidköping Biogas, FordonsGas Sverige will get an even better control over the production chain and can further develop sustainable mobility.

The Vinge team advising Air Liquide Advanced Business S.A./FordonsGas Sverige AB consists of Jesper Ottergren together with Anna Edström and, inter alia, Christoffer Thalin, Mathias Lindquist, Emma Hakesjö and Cecilia Cronquist.

Related

Vinge advises Atria Sverige in conjunction with an investment in Cookin Food

 Atria Sverige has acquired a 25 per cent stake in the Swedish convenience food company Cookin Food Sweden AB. The transaction has been performed through the acquisition of shares in Bite Delight AB, which owns Cookin Food Sweden AB. Atria holds an option to acquire the remaining shares in Bite Delight AB after 2028.
March 04, 2026

Vinge advises Revivo Group on the acquisition of Solidenergy

 Revivo Group, a portfolio company of Helix Kapital, has acquired Solidenergy, a leading provider of surface treatment services in the Norwegian market. The company operates within the energy, offshore and infrastructure sectors and is headquartered in Ågotnes outside Bergen. Solidenergy employs approximately 600 people.
March 03, 2026

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a partially guaranteed rights issue which is expected to provide Oncopeptides with proceeds of approximately SEK 200 million before deduction of transaction costs.
March 03, 2026